Overview
Vedran Radojcic is a Hematologist practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 18 years.
Dr. Radojcic is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.
He is actively involved in clinical research, co-authoring 23 peer reviewed articles and participating in 1 clinical trial.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- POS
- PPO
Locations
3621 S State St # 700, Ann Arbor, MI 48108
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
C. S. Mott Children's Hospital
Dr. Dale Bixby has been practicing hematology at the University of Michigan since 2009. He obtained his PhD in Medicinal Chemistry and Pharmaceutics at the University of Kentucky in 1999, before beginning his medical training at the University of Michigan in Ann Arbor, MI. He was a resident in the Department of Internal Medicine and then completed fellowship training in hematology and medical oncology at the University of Michigan. Dr. Bixby is currently a clinical professor and specializes in the areas of myeloid and lymphoid leukemias, myelodysplastic syndrome and bone marrow failure disorders. Dr. Bixby currently serves as the section chief of the acute leukemia program. He is also a clinical investigator in hematological malignancies. Dr. Bixby is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia (CML), and Bone Marrow Aspiration. Dr. Bixby is board certified in Hematology.
Rogel Cancer Center
Erica Campagnaro is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Campagnaro is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Campagnaro is board certified in Internal Medicine and Hematology.
University Of Michigan Medical Center
Rajen Mody is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Mody is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Infantile Neutropenia, Glioma, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Vedran Radojcic
How do I make an appointment with Dr. Vedran Radojcic?
You can book an appointment with Dr. Vedran Radojcic by calling their office at 734-936-9814. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Vedran Radojcic a top-rated expert for Graft Versus Host Disease (GvHD)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Vedran Radojcic is classified as an Elite expert for Graft Versus Host Disease (GvHD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Vedran Radojcic specialize in?
While Dr. Vedran Radojcic is a Hematology, they have specific expertise in Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), and Bone Marrow Transplant. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Vedran Radojcic participate in research or clinical trials?
Yes. Dr. Vedran Radojcic has published 23 articles and abstracts on conditions like Graft Versus Host Disease (GvHD). You can view a list of Dr. Vedran Radojcic's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Vedran Radojcic accept my insurance?
Dr. Vedran Radojcic accepts most major insurance plans, including Humana and UnitedHealthcare. We recommend calling the office directly at 734-936-9814 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Graft Versus Host Disease (GvHD)
- Distinguished
- Chronic Graft Versus Host Disease (cGvHD)Dr. Radojcic isDistinguished. Learn about Chronic Graft Versus Host Disease (cGvHD).
- Advanced
- Bone Marrow TransplantDr. Radojcic isAdvanced. Learn about Bone Marrow Transplant.
- Experienced
- Acute Myeloblastic Leukemia with MaturationDr. Radojcic isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Radojcic isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Bone Marrow AspirationDr. Radojcic isExperienced. Learn about Bone Marrow Aspiration.
- Childhood Acute Myeloid LeukemiaDr. Radojcic isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- ColonoscopyDr. Radojcic isExperienced. Learn about Colonoscopy.